Toggle light / dark theme

Neuroprosthetics: Medicine of the future

Neuroprosthesis is the process of using direct electric stimulation to enable proper functioning of the nervous system. Neuroprosthetic devices supplements the input or the output signals to the neural system, enabling the individual to carry out proper functioning and physical activities. Some of the purposes which involve the use of neuroprosthetics include, techniques for bladder and bowel control, deep brain stimulation, and restoration of mobility and respiration to paralyzed individuals.

Get PDF sample copy of study @ http://bit.ly/39hTnku

Brain disorders exhibits a considerable social and economic burden in Europe. According to WHO survey, brain disorders are responsible for 35% of Europe’s total disease burden. This burden is increasing due to increasing number of aging population in Europe, and requires a considerable attention to address the treatment issues as all the cases does not respond to medication therapy.

Utilizing Biopharma 4.0 to Boost Coronavirus 2019-nCoV Vaccine Efforts

Scientists are scrambling to develop a vaccine against coronavirus 2019-nCoV and plan to use advanced bioprocessing methods and techniques to accelerate production.

#coronavirus #vaccine #bioprocessing


At present there is no vaccine against the coronavirus However, various groups have started working on them, including Johnson & Johnson (J&J).

Sarah Smith, senior manager, communications & public affairs, EMEA at J&J’s Janssen unit, tells GEN that, “We began working on a vaccine two weeks ago, when the viral sequence became publicly available, and are hopeful that we can create a candidate vaccine for this virus and can start a Phase I clinical study within approximately 8–12 months. If necessary, we will work to scale up production of a suitable vaccine candidate in parallel. While it is possible that the virus could disappear relatively fast, we started the work quickly because we want to be prepared.”

Development and production will leverage Janssen’s AdVac vector technology and PER.C6 manufacturing platform, which were previously used to make an investigational Ebola vaccine, currently deployed in the Democratic Republic of the Congo and Rwanda. According to Smith, “We will use single-use technology in order to produce larger quantities of the vaccine on a flexible schedule at a later moment in time.” She also says that most manufacturing would be carried out in house, adding that “for fill/finish activities, we will utilize external CMOs.”

Robot completes first round of “supermicrosurgeries” on human patients

A highly precise form of reconstructive surgery, known as supermicrosurgery, seeks to connect ultra-thin blood and lymph vessels as a way of restoring them to healthy function. This requires a high level of expertise on part of the surgeons, but they may soon have a new robotic tool at their disposal called Musa, which has performed its first round of procedures with great success.

Supermicrosurgery is a relatively new medical technique that focuses on reconnecting vessels with diameters ranging from 0.3 mm to 0.8 mm. One of its primary applications is tackling lymphedema, which commonly occurs following breast cancer treatment and leads to swelling and localized fluid retention. Given the delicate nature of the process, only a small number of surgeons are currently capable of performing these operations.

Microsure is a Dutch startup spun out of Eindhoven University of Technology and Maastricht University Medical Centre, where researchers have been developing a robot to take on the task of supermicrosurgery. Called Musa, the robot is controlled by a surgeon, but translates their hand movements into more precise actions for a set of robotic hands.

Top CDC official says US should prepare for coronavirus ‘to take a foothold’

The Centers for Disease Control and Prevention said Wednesday it is preparing for the new coronavirus, which has killed at least 1,115 and sickened more than 45,000 worldwide, to “take a foothold in the U.S.”

“At some point, we are likely to see community spread in the U.S. or in other countries,” Dr. Nancy Messonnier, director of the CDC’s National Center for Immunization and Respiratory Diseases, told reporters on a conference call. “This will trigger a change in our response strategy.”

AI Predicts Coronavirus Vulnerable to HIV’s Atazanavir

An international collaboration between researchers at Deargen and Dankook University in the Republic of Korea, and Emory University in the United States, have published a prediction model for antiviral drugs that may be effective on 2019-nCoV.

The work is published in the article “Predicting commercially available antiviral drugs that may act on the novel coronavirus (2019-nCoV), Wuhan, China, through a drug-target interaction deep learning model” posted on the bioRxiv preprint server.


When an international team used an AI model to suggest available drugs that could be used against 2019-nCoV, the top candidates targeted viral proteinases.

How AI Is Advancing NeuroTech

The idea is to use AI to develop a platform for detecting biomarkers from neural data. Then long-life neural interfaces (connections that allow computers to read and write neural data directly to and from the body) could be combined with a deep intelligence system trained to assess biomarkers directly from neural data.

If the AI platform is able to understand the “language” of the nervous system it could be used in closed-loop experiments to test neuromodulation therapy on new targets. This could accelerate the development of treatments for a number of chronic conditions and would also be a big step closer to real-world clinical applications of AI within the body. This progress could create a new way to investigate medical conditions, accelerate the detection of neural biomarkers, and open the door to a new generation of AI-based neural medical procedures.

NeuroTech is one of the most promising areas of BioTech. In the last 20 years private capital funds invested more than $19 billion in the sector, and annual growth of investment in the sector is 31%. Some NeuroTech subsectors are already well-established with practical implementations and products on the market. Over the next several years, many early-stage startups will evolve into mature companies and bring new NeuroTech products to market. Advances in AI and increased integration of computers and biology could lead to improved brain health for people all over the world.

The Information in DNA Is Decoded by Transcription

DNA is essentially a storage molecule. It contains all of the instructions a cell needs to sustain itself. These instructions are found within genes, which are sections of DNA made up of specific sequences of nucleotides. In order to be implemented, the instructions contained within genes must be expressed, or copied into a form that can be used by cells to produce the proteins needed to support life.

The instructions stored within DNA are read and processed by a cell in two steps: transcription and translation. Each of these steps is a separate biochemical process involving multiple molecules. During transcription, a portion of the cell’s DNA serves as a template for creation of an RNA molecule. (RNA, or ribonucleic acid, is chemically similar to DNA, except for three main differences described later on in this concept page.) In some cases, the newly created RNA molecule is itself a finished product, and it serves an important function within the cell. In other cases, the RNA molecule carries messages from the DNA to other parts of the cell for processing. Most often, this information is used to manufacture proteins. The specific type of RNA that carries the information stored in DNA to other areas of the cell is called messenger RNA, or mRNA.

/* */